Lanib 250mg is utilized with the drug capecitabine for the treatment of patients with cutting edge or metastatic bosom disease that is HER2 positive (tumors that produce a lot of a protein called human epidermal development factor receptor-2), and who have just had certain other bosom malignancy medicines.
Lanib 250mg is additionally utilized with a sort of prescription called letrozole for the treatment of postmenopausal ladies with hormone receptor positive, HER2 positive metastatic bosom malignant growth for whom hormonal treatment is shown.
Lanib 250mg in blend with an aromatase inhibitor has not been contrasted with a trastuzumab-containing chemotherapy routine for the treatment of metastatic bosom malignant growth.
Lapatinib is utilized together with another drug (capecitabine) to treat a particular kind of bosom malignant growth (HER2-positive) that has not reacted to the standard treatment. Lapatinib may likewise be utilized together with another drug (letrozole) to treat HER2-positive bosom disease in ladies after menopause.
- Dry skin
- Hair loss
- Mouth sores